Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
12.67
+0.28 (2.26%)
At close: Nov 10, 2026, 4:00 PM EST
12.51
-0.16 (-1.26%)
Pre-market: Nov 11, 2026, 5:14 AM EST
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $133.62 million as of November 10, 2026. It is the 23,059th most valuable company in the world and the 3,852nd biggest in the United States. Its market cap has increased by 5.27% in one year.
Market Cap
133.62M
Enterprise Value
78.90M
1-Year Change
5.27%
Global Rank
Country Rank
#3,852 United States
Category
ChartMarket Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $133.62M, a decrease of -94.67%. That is a compound annual growth rate of -36.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 133.62M | -38.41% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 1.28B |
| Freenome | 1.09B |
| Castle Biosciences | 1.00B |
| Fulgent Genetics | 663.27M |
| Myriad Genetics | 567.86M |
| Exagen | 140.75M |
| Biodesix | 90.00M |
| Insight Molecular Diagnostics | 81.48M |